DSM-Firmenich stock

DSFIR · Euronext Amsterdam · EUR

€104.10Change from previous close: −1.42%Absolute change: −€1.50

Close · November 16, 2026

Price history

+47.20% over the period

1 year: from €70.72 (November 17, 2025) to €104.10 (November 16, 2026), +47.20%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 16, 2026€104.10
October 30, 2026€106.75
September 30, 2026€97.58
August 31, 2026€95.74
July 31, 2026€93.38
June 30, 2026€83.00
May 29, 2026€72.16
April 30, 2026€63.56
March 31, 2026€61.44
February 27, 2026€60.44
January 30, 2026€66.20
December 31, 2025€68.76
November 28, 2025€70.76
November 17, 2025€70.72

At a glance

  • The company

    Provides nutrition, health, and beauty solutions including fragrances, food ingredients, vitamins, and pharmaceutical ingredients globally

  • Latest results

    Quarter to June 30, 2026 · EPS €0.88 (estimate €0.91)

TickerLandia's take on DSM-Firmenich

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€55.22
52-wk high€113.45

−8.24% from the 52-week high

Analysts · 20 analysts

Average target€102.12−1.90% vs. price

Buy 7 · Hold 12 · Sell 1 · Buy

TickerLandia Fingerprint: DSM-Firmenich

Compared with similar companies: very strong momentum, very low profitability, and very low earnings stability.

Financials and price compared with 59 companies in the specialty chemicals industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

DSM-Firmenich is pricier than similar companies

DSM-Firmenich's P/E (trailing 12 months): 63.4, +52% against the median of a group of 11 similar companies (41.7).

Compared with 11 similar companies

DSM-Firmenich's metrics compared with similar companies
MetricDSM-FirmenichPosition in the groupBand
P/E (trailing 12 months)63.4High
Forward P/E25.2Middle
Operating margin6.8%Low
ROE1.9%Low
Debt/equity0.38Middle

Grey band: the middle half of the group; tick: the median; dot: DSM-Firmenich. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€4.66B

Latest quarter · Q2 2026

Net income

€212M

Latest quarter · Q2 2026

Quarterly net margin

4.5%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
€25.8B
P/E
63.4
EPS
-€5.36
Volume
338K
Daily trading
€64.41M
Dividend yield
2.38%
Last ex-dividend on May 11, 2026

How DSM-Firmenich is changing

All results
  • Revenue grew 2.2% a year on average over the last 5 years

  • Shares outstanding up 50.4% in 5 years

  • Profitable in 4 of 5 fiscal years

Returns

DSM-Firmenich returns with dividends

€1,000 invested in DSM-Firmenich 3 years ago, on November 16, 2023, would be worth €1,237 today with dividends reinvested: +23.72% in total, +7.35% per year. On price alone it would be €1,132 (+13.21%).

PeriodDSM-FirmenichAEX€1,000 becomes
1 month−2.76%+1.03%€972
6 months+57.73%+12.92%€1,577
Year to date+51.40%+19.94%€1,514
1 year+52.82%+20.69%€1,528
3 years+23.72%+51.34%€1,237

Over the last 6 months it has done better than 95% of the stocks in the Consumer sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. AEX: price only. Calculate your investment

The chart in detail

DSM-Firmenich: technical analysis

DSM-Firmenich is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 15.8% below its all-time closing high (€123.65, September 30, 2024).

Trend
Upward
RSI (14 sessions)
47
Between 30 and 70
vs 200-session average
+29.66%

Support and resistance

Price areas where DSM-Firmenich has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price€104.10
  3. Support€96.42−7.38%2 touches, last on November 4, 2026
  4. Support€94.37−9.35%2 touches, last on October 2, 2026
  5. Support€86.89−16.53%3 touches, last on August 18, 2026

Volatility and risk

Over the last year it has moved less than the AEX.

Beta (1 year) vs AEX
0.72
Volatility (60 sessions, annualised)
26.9%
Largest fall in the last year
−22.53%

In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

DSM-Firmenich and its competitors

DSM-Firmenich AG operates through three segments: Perfumery & Beauty, which creates scents from natural, synthetic and biotech ingredients; Taste, Texture & Health, which supplies flavors, natural extracts, food enzymes, hydrocolloids, cultures, natural colorants and plant-based proteins to food and beverage makers; and Health, Nutrition & Care, which offers vitamins, nutritional lipids, probiotics and prebiotics, active pharmaceutical ingredients and biomedical solutions to dietary supplement, pharmaceutical, early life and medical nutrition markets.

Headquarters
Kaiseraugst, Switzerland
Employees
20,786
Founded
1902
Chief executive
Dimitri de Vreeze
DSM-Firmenich and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
DSM-FirmenichDSFIR$28.52B6.8%63.4+57.73%
NovozymesNSIS.B$31.63B23.4%42.1+20.47%
EMS-CHEMIE HOLDINGEMSN$23.88B29.9%42.3+28.25%
SikaSIKA$36.73B13.6%29.6+38.19%
GivaudanGIVN$45.03B17.9%39.8+51.26%
SymriseSY1$14.06B12.6%52.6+29.50%

Same industry or related industries, similar size. Compare DSM-Firmenich with its competitors · Full profile